nodes	percent_of_prediction	percent_of_DWPC	metapath
Encainide—CYP2D6—epilepsy syndrome	0.269	1	CbGaD
Encainide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.126	0.187	CbGbCtD
Encainide—SCN5A—Fosphenytoin—epilepsy syndrome	0.11	0.164	CbGbCtD
Encainide—SCN5A—Lamotrigine—epilepsy syndrome	0.0916	0.137	CbGbCtD
Encainide—SCN5A—Rufinamide—epilepsy syndrome	0.0809	0.121	CbGbCtD
Encainide—SCN5A—Carbamazepine—epilepsy syndrome	0.0788	0.118	CbGbCtD
Encainide—SCN5A—Phenytoin—epilepsy syndrome	0.0707	0.105	CbGbCtD
Encainide—SCN5A—Zonisamide—epilepsy syndrome	0.0583	0.0869	CbGbCtD
Encainide—SCN5A—Topiramate—epilepsy syndrome	0.0425	0.0634	CbGbCtD
Encainide—CYP2D6—Propofol—epilepsy syndrome	0.0126	0.0188	CbGbCtD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN8A—epilepsy syndrome	0.00247	0.0436	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN9A—epilepsy syndrome	0.00247	0.0436	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN4A—epilepsy syndrome	0.00247	0.0436	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN3A—epilepsy syndrome	0.00247	0.0436	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—KCNQ2—epilepsy syndrome	0.00198	0.0348	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—KCNQ3—epilepsy syndrome	0.00198	0.0348	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN1B—epilepsy syndrome	0.00187	0.033	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN1A—epilepsy syndrome	0.00187	0.033	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SCN2A—epilepsy syndrome	0.00159	0.0281	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—ANK3—epilepsy syndrome	0.0013	0.0229	CbGpPWpGaD
Encainide—SCN5A—Interaction between L1 and Ankyrins—SPTAN1—epilepsy syndrome	0.00117	0.0206	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN9A—epilepsy syndrome	0.000948	0.0167	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN3A—epilepsy syndrome	0.000948	0.0167	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN4A—epilepsy syndrome	0.000948	0.0167	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN8A—epilepsy syndrome	0.000948	0.0167	CbGpPWpGaD
Encainide—CYP2D6—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000858	0.0151	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.000848	0.015	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—KCNQ3—epilepsy syndrome	0.000758	0.0134	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—KCNQ2—epilepsy syndrome	0.000758	0.0134	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN1B—epilepsy syndrome	0.000719	0.0127	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN1A—epilepsy syndrome	0.000719	0.0127	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—DCX—epilepsy syndrome	0.000657	0.0116	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SCN2A—epilepsy syndrome	0.000611	0.0108	CbGpPWpGaD
Encainide—CYP2D6—CYP2E1 reactions—CYP2C19—epilepsy syndrome	0.000551	0.00972	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—CNTN2—epilepsy syndrome	0.00052	0.00916	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—BMP4—epilepsy syndrome	0.000516	0.00911	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—ANK3—epilepsy syndrome	0.000498	0.00879	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000487	0.0086	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000487	0.0086	CbGpPWpGaD
Encainide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000455	0.00803	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SPTAN1—epilepsy syndrome	0.000448	0.00791	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—MAP2—epilepsy syndrome	0.000442	0.00779	CbGpPWpGaD
Encainide—Zafirlukast—ABCG2—epilepsy syndrome	0.000405	0.118	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000379	0.00668	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000369	0.00651	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN9A—epilepsy syndrome	0.000358	0.00632	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN3A—epilepsy syndrome	0.000358	0.00632	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN4A—epilepsy syndrome	0.000358	0.00632	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN8A—epilepsy syndrome	0.000358	0.00632	CbGpPWpGaD
Encainide—CYP2D6—Xenobiotics—CYP2C19—epilepsy syndrome	0.000342	0.00603	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000338	0.00596	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000338	0.00596	CbGpPWpGaD
Encainide—CYP2D6—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000329	0.0058	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000325	0.00574	CbGpPWpGaD
Encainide—Zafirlukast—CYP2C19—epilepsy syndrome	0.000319	0.093	CrCbGaD
Encainide—Eletriptan—HTR7—epilepsy syndrome	0.000315	0.092	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000314	0.00554	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—MEF2C—epilepsy syndrome	0.000304	0.00537	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—ITGA2—epilepsy syndrome	0.000304	0.00535	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KCNQ2—epilepsy syndrome	0.000286	0.00505	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KCNQ3—epilepsy syndrome	0.000286	0.00505	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CACNB4—epilepsy syndrome	0.000272	0.00479	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN1B—epilepsy syndrome	0.000272	0.00479	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SCN1A—epilepsy syndrome	0.000272	0.00479	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000267	0.00471	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000267	0.00471	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—DLG4—epilepsy syndrome	0.00026	0.00458	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN3A—epilepsy syndrome	0.000256	0.00451	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN8A—epilepsy syndrome	0.000256	0.00451	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN9A—epilepsy syndrome	0.000256	0.00451	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN4A—epilepsy syndrome	0.000256	0.00451	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.000254	0.00448	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—KDR—epilepsy syndrome	0.000252	0.00445	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000251	0.00443	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—DCX—epilepsy syndrome	0.000248	0.00438	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CACNA1H—epilepsy syndrome	0.000248	0.00438	CbGpPWpGaD
Encainide—Zafirlukast—CYP2D6—epilepsy syndrome	0.000236	0.0689	CrCbGaD
Encainide—SCN5A—Axon guidance—SCN2A—epilepsy syndrome	0.000231	0.00407	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CACNA1G—epilepsy syndrome	0.000231	0.00407	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000225	0.00398	CbGpPWpGaD
Encainide—Clemastine—CYP2D6—epilepsy syndrome	0.000215	0.0626	CrCbGaD
Encainide—Mesoridazine—CHRM2—epilepsy syndrome	0.000211	0.0615	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000205	0.00361	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KCNQ3—epilepsy syndrome	0.000204	0.00361	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KCNQ2—epilepsy syndrome	0.000204	0.00361	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CNTN2—epilepsy syndrome	0.000196	0.00346	CbGpPWpGaD
Encainide—SCN5A—Cardiac Progenitor Differentiation—FGF2—epilepsy syndrome	0.000195	0.00345	CbGpPWpGaD
Encainide—Eletriptan—CYP2C19—epilepsy syndrome	0.000195	0.057	CrCbGaD
Encainide—SCN5A—Developmental Biology—CACNB4—epilepsy syndrome	0.000194	0.00342	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN1A—epilepsy syndrome	0.000194	0.00342	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SCN1B—epilepsy syndrome	0.000194	0.00342	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.00019	0.00336	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SLIT2—epilepsy syndrome	0.000188	0.00332	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ANK3—epilepsy syndrome	0.000188	0.00332	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000185	0.00326	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000185	0.00326	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000184	0.00325	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000183	0.00322	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CACNA1D—epilepsy syndrome	0.000181	0.0032	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CACNA1H—epilepsy syndrome	0.000177	0.00313	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—DCX—epilepsy syndrome	0.000177	0.00313	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—GDNF—epilepsy syndrome	0.000175	0.00309	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.00017	0.00299	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SPTAN1—epilepsy syndrome	0.000169	0.00299	CbGpPWpGaD
Encainide—Diltiazem—CYP2C19—epilepsy syndrome	0.000166	0.0485	CrCbGaD
Encainide—SCN5A—Developmental Biology—SCN2A—epilepsy syndrome	0.000165	0.00291	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CACNA1G—epilepsy syndrome	0.000165	0.00291	CbGpPWpGaD
Encainide—Thioridazine—CHRM2—epilepsy syndrome	0.000159	0.0464	CrCbGaD
Encainide—Thioridazine—HTR7—epilepsy syndrome	0.000158	0.0462	CrCbGaD
Encainide—Eletriptan—CYP2D6—epilepsy syndrome	0.000145	0.0423	CrCbGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000142	0.0025	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000141	0.00249	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.00014	0.00247	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CNTN2—epilepsy syndrome	0.00014	0.00247	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00014	0.00247	CbGpPWpGaD
Encainide—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000139	0.00245	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000138	0.00244	CbGpPWpGaD
Encainide—Thioridazine—ADRA2A—epilepsy syndrome	0.000136	0.0396	CrCbGaD
Encainide—SCN5A—Developmental Biology—ANK3—epilepsy syndrome	0.000134	0.00237	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SLIT2—epilepsy syndrome	0.000134	0.00237	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000133	0.00234	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—PRNP—epilepsy syndrome	0.000133	0.00234	CbGpPWpGaD
Encainide—CYP2D6—Melatonin metabolism and effects—APOE—epilepsy syndrome	0.00013	0.00229	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CACNA1D—epilepsy syndrome	0.000129	0.00228	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000128	0.00226	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—GDNF—epilepsy syndrome	0.000125	0.0022	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000124	0.00219	CbGpPWpGaD
Encainide—Diltiazem—CYP2D6—epilepsy syndrome	0.000123	0.036	CrCbGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000123	0.00216	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000122	0.00215	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SPTAN1—epilepsy syndrome	0.000121	0.00213	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ACTB—epilepsy syndrome	0.000117	0.00206	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000117	0.00206	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000115	0.00203	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—ITGA2—epilepsy syndrome	0.000115	0.00202	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000114	0.00202	CbGpPWpGaD
Encainide—Mesoridazine—HTR2A—epilepsy syndrome	0.000105	0.0308	CrCbGaD
Encainide—Eletriptan—ABCB1—epilepsy syndrome	0.000103	0.0302	CrCbGaD
Encainide—SCN5A—Developmental Biology—TCF4—epilepsy syndrome	9.98e-05	0.00176	CbGpPWpGaD
Encainide—Thioridazine—CYP2C19—epilepsy syndrome	9.81e-05	0.0286	CrCbGaD
Encainide—SCN5A—Axon guidance—DLG4—epilepsy syndrome	9.81e-05	0.00173	CbGpPWpGaD
Encainide—Mesoridazine—CYP2D6—epilepsy syndrome	9.64e-05	0.0281	CrCbGaD
Encainide—SCN5A—Axon guidance—GRIN2B—epilepsy syndrome	9.59e-05	0.00169	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—PRNP—epilepsy syndrome	9.46e-05	0.00167	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CDH2—epilepsy syndrome	8.9e-05	0.00157	CbGpPWpGaD
Encainide—SCN5A—L1CAM interactions—SRC—epilepsy syndrome	8.87e-05	0.00156	CbGpPWpGaD
Encainide—Diltiazem—ABCB1—epilepsy syndrome	8.8e-05	0.0257	CrCbGaD
Encainide—SCN5A—Axon guidance—ADAM10—epilepsy syndrome	8.64e-05	0.00152	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ACTB—epilepsy syndrome	8.33e-05	0.00147	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ITGA2—epilepsy syndrome	8.19e-05	0.00144	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—CDC42—epilepsy syndrome	8.07e-05	0.00142	CbGpPWpGaD
Encainide—Thioridazine—HTR2A—epilepsy syndrome	7.96e-05	0.0232	CrCbGaD
Encainide—Thioridazine—CYP2D6—epilepsy syndrome	7.28e-05	0.0212	CrCbGaD
Encainide—SCN5A—Axon guidance—FYN—epilepsy syndrome	7.19e-05	0.00127	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—DLG4—epilepsy syndrome	7e-05	0.00123	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	6.92e-05	0.00122	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	6.9e-05	0.00122	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—GRIN2B—epilepsy syndrome	6.84e-05	0.00121	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	6.7e-05	0.00118	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—AKT3—epilepsy syndrome	6.31e-05	0.00111	CbGpPWpGaD
Encainide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	6.23e-05	0.0011	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—ADAM10—epilepsy syndrome	6.17e-05	0.00109	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	6.11e-05	0.00108	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	6.07e-05	0.00107	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.03e-05	0.00106	CbGpPWpGaD
Encainide—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.99e-05	0.00106	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—KDR—epilepsy syndrome	5.92e-05	0.00104	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	5.86e-05	0.00103	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—CDC42—epilepsy syndrome	5.76e-05	0.00102	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—IL6ST—epilepsy syndrome	5.68e-05	0.001	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—HES1—epilepsy syndrome	5.27e-05	0.00093	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FYN—epilepsy syndrome	5.13e-05	0.000905	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MEF2C—epilepsy syndrome	5.1e-05	0.0009	CbGpPWpGaD
Encainide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.05e-05	0.000891	CbGpPWpGaD
Encainide—SCN5A—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.02e-05	0.000885	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—KDR—epilepsy syndrome	4.23e-05	0.000746	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CA13—epilepsy syndrome	4.18e-05	0.000737	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	4.05e-05	0.000715	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—MMP9—epilepsy syndrome	3.63e-05	0.000641	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—SRC—epilepsy syndrome	3.35e-05	0.000591	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	3.28e-05	0.000578	CbGpPWpGaD
Encainide—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	3.26e-05	0.000576	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PDXK—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CERS1—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ADK—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—FAR1—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	3.17e-05	0.000559	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—RELA—epilepsy syndrome	3.04e-05	0.000537	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GAMT—epilepsy syndrome	2.9e-05	0.000511	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PNPO—epilepsy syndrome	2.9e-05	0.000511	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	2.9e-05	0.000511	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	2.9e-05	0.000511	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—QDPR—epilepsy syndrome	2.69e-05	0.000475	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CA4—epilepsy syndrome	2.69e-05	0.000475	CbGpPWpGaD
Encainide—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	2.68e-05	0.000474	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	2.59e-05	0.000457	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—COX3—epilepsy syndrome	2.53e-05	0.000447	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	2.4e-05	0.000423	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	2.4e-05	0.000423	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	2.4e-05	0.000423	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	2.4e-05	0.000423	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	2.4e-05	0.000423	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—SRC—epilepsy syndrome	2.39e-05	0.000422	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	2.33e-05	0.000411	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	2.2e-05	0.000387	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	2.2e-05	0.000387	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	2.2e-05	0.000387	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	2.11e-05	0.000373	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	2.04e-05	0.00036	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	2.04e-05	0.00036	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—TNF—epilepsy syndrome	2e-05	0.000352	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.92e-05	0.000338	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.87e-05	0.000329	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.82e-05	0.000321	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.82e-05	0.000321	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.74e-05	0.000306	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.74e-05	0.000306	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.7e-05	0.0003	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.66e-05	0.000293	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.63e-05	0.000288	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.6e-05	0.000282	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.5e-05	0.000264	CbGpPWpGaD
Encainide—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.49e-05	0.000262	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.45e-05	0.000257	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.32e-05	0.000232	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.32e-05	0.000232	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.07e-05	0.000189	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.04e-05	0.000184	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.04e-05	0.000183	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.92e-06	0.000157	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.88e-06	0.000157	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.48e-06	0.000149	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.38e-06	0.000148	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—TH—epilepsy syndrome	8.35e-06	0.000147	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.97e-06	0.000123	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.88e-06	0.000121	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.69e-06	0.000118	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.22e-06	0.00011	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.45e-06	9.62e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.34e-06	9.43e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.59e-06	8.1e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.19e-06	7.38e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.66e-06	6.46e-05	CbGpPWpGaD
Encainide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.84e-06	3.25e-05	CbGpPWpGaD
